Catherine Sperlich

587 total citations
8 papers, 33 citations indexed

About

Catherine Sperlich is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Genetics. According to data from OpenAlex, Catherine Sperlich has authored 8 papers receiving a total of 33 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 3 papers in Oncology and 2 papers in Genetics. Recurrent topics in Catherine Sperlich's work include Chronic Lymphocytic Leukemia Research (2 papers), Prostate Cancer Treatment and Research (2 papers) and Cancer Treatment and Pharmacology (2 papers). Catherine Sperlich is often cited by papers focused on Chronic Lymphocytic Leukemia Research (2 papers), Prostate Cancer Treatment and Research (2 papers) and Cancer Treatment and Pharmacology (2 papers). Catherine Sperlich collaborates with scholars based in Canada, United States and France. Catherine Sperlich's co-authors include Jamil Asselah, Fred Saad, William Semchuk, Nghia T. Nguyen, Susan Fox, Djamal Berbiche, Benoît Samson, C. Tournigand, Jean Latreille and Susan Solymoss and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Thrombosis and Haemostasis.

In The Last Decade

Catherine Sperlich

8 papers receiving 33 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine Sperlich Canada 4 19 10 7 7 6 8 33
Muhammad Saad Hamid United States 4 19 1.0× 15 1.5× 3 0.4× 3 0.4× 3 0.5× 10 36
Nicola Jackson United Kingdom 5 13 0.7× 17 1.7× 7 1.0× 19 2.7× 8 1.3× 9 52
Gurdeep Parmar Australia 5 12 0.6× 23 2.3× 7 1.0× 23 3.3× 17 2.8× 15 51
Beatriz Rojas Spain 3 7 0.4× 18 1.8× 7 1.0× 2 0.3× 5 0.8× 7 30
Alice R.T. Bergin Australia 5 15 0.8× 15 1.5× 3 0.4× 2 0.3× 13 2.2× 8 41
B. Diorio United States 3 20 1.1× 21 2.1× 4 0.6× 2 0.3× 8 1.3× 7 24
Maud Simansour France 5 6 0.3× 9 0.9× 7 1.0× 11 1.6× 31 5.2× 5 58
Maddalena Marconato Germany 4 7 0.4× 11 1.1× 2 0.3× 4 0.6× 6 1.0× 8 32
Rashmi Khanal United States 4 12 0.6× 23 2.3× 3 0.4× 8 1.1× 16 2.7× 15 42
Laura Leroy France 3 18 0.9× 28 2.8× 5 0.7× 4 0.7× 8 36

Countries citing papers authored by Catherine Sperlich

Since Specialization
Citations

This map shows the geographic impact of Catherine Sperlich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Sperlich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Sperlich more than expected).

Fields of papers citing papers by Catherine Sperlich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Sperlich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Sperlich. The network helps show where Catherine Sperlich may publish in the future.

Co-authorship network of co-authors of Catherine Sperlich

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Sperlich. A scholar is included among the top collaborators of Catherine Sperlich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Sperlich. Catherine Sperlich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Carrier, Marc, Catherine Sperlich, Susan Solymoss, et al.. (2022). Step down to 6 months of prophylactic‐dose low molecular weight heparin after initial full‐dose anticoagulation for the treatment of cancer‐associated thrombosis (STEP‐CAT): A pilot study. Journal of Thrombosis and Haemostasis. 20(8). 1868–1874. 1 indexed citations
2.
Sperlich, Catherine, et al.. (2022). Refractory immune TTP following Pfizer‐BioNTech COVID‐19 vaccine successfully salvaged with caplacizumab. Journal of Thrombosis and Haemostasis. 20(7). 1696–1698. 2 indexed citations
5.
Asselah, Jamil & Catherine Sperlich. (2013). Post-docetaxel options for further survival benefit in metastatic castration-resistant prostate cancer: Questions of choice. Canadian Urological Association Journal. 7(2). S11–7. 10 indexed citations
6.
Sperlich, Catherine & Fred Saad. (2013). Optimal management of patients receiving cabazitaxel-based chemotherapy. Canadian Urological Association Journal. 7(2). S18–24. 7 indexed citations
7.
Semchuk, William & Catherine Sperlich. (2012). Prevention and Treatment of Venous Thromboembolism in Patients with Cancer. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 145(1). 24–29.e1. 3 indexed citations
8.
Samson, Benoît, Jean Latreille, Nghia T. Nguyen, et al.. (2011). SUNCAP, a phase II study with sunitinib and capecitabine in patients with metastatic colorectal cancer (MCRC) refractory to previous treatment with 5FU/irinotecan/oxaliplatin.. Journal of Clinical Oncology. 29(4_suppl). 545–545. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026